MarginsXMarginsX
Home › Markets › Health Care › HYPR

Hyperfine Inc. (HYPR)

HYPR trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.6101
-3.05% on the day
Market cap
$64.8M
Micro cap
Revenue · 2025
$13.6M
+5.2% on 2024
Net income · 2025
-$35.6M
-262.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1833769/000119312526114044/0001193125-26-114044-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerHYPR on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year2021
SEC CIK0001833769
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$13.6M
Net income-$35.6M
Operating income-$37.1M
Net margin-262.3%
Operating margin-273.4%
Revenue growth+5.2%
Cash$35.1M
Total assets$55.3M
P/E (computed)Net income was not positive
P/S (computed)4.8×

Warning signs

Cash runway
16.5 months
$37.9M cash at September 30, 2026
Share count, 1 year
+9.3%
2025-10-31 to 2026-11-04
Going-concern doubt
No
10-Q filed November 9, 2026
Insider net buying, 12 months
-$48K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.
"There can be no assurance that the Company will be able to obtain such working capital on acceptable terms or at all which could result in management concluding in the future that there is substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-11-09
Cash and burn$37.9M cash; operating cash flow -$6.9M a quarter.Report 2026-09-30
Shares outstanding106,199,172 (2026-11-04); 97,168,657 a year earlier.Cover page 2026-11-04
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2025-12-29
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-09-18
AuditorGrant Thornton LLP, San Jose, California, United StatesPCAOB Form AP 2026-03-23
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $48K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$6.0M-$6.0M-$6.1M$37.9M$13.4M$19.1M10-Q 2026-11-09
Q2 2026
2026-06-30
$3.9M-$9.3M-$7.3M$43.5M$13.2M$16.5M10-Q 2026-08-06
Q1 2026
2026-03-31
$3.9M-$8.6M-$9.0M$40.8M$13.1M$15.3M10-Q 2026-05-12
Q4 2025
2025-12-31
$5.3M-$5.9M-$5.2M$35.1M$0$13.6M10-K 2026-03-18
Q3 2025
2025-09-30
$3.4M-$11.0M-$5.6M$21.6MNo debt tags$10.6M10-Q 2026-11-09
Q2 2025
2025-06-30
$2.7M-$9.2M-$7.9M$25.4MNo debt tags$10.8M10-Q 2026-08-06
Q1 2025
2025-03-31
$2.1M-$9.4M-$9.2M$33.1MNo debt tags$11.7M10-Q 2026-05-12
Q4 2024
2024-12-31
$2.3M-$10.4M-$8.4M$37.6MNo debt tags$12.9M10-K 2026-03-18

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32026-11-09
Latest annual report10-K2026-03-18
Latest quarterly / interim10-Q2026-11-09
Latest current report8-K2026-11-09
Latest proxyDEFA14A2026-04-08

Source: SEC EDGAR submissions feed, 370 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-12.6%
1 month-26.2%
3 months-29.6%
Year to date-35.8%
1 year-40.1%
From 52-week high-66.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
OMOutset Medical Inc.$3.39-9.12%$64.0M
NRXSNeuraxis Inc.$4.80-11.44%$68.1M
POCIPrecision Optics Corporation Inc.$4.97-4.97%$54.6M
STXSStereotaxis Inc.$0.8027-4.80%$80.4M
VANIVivani Medical Inc. Common Stock (DE)$1.02+0.99%$92.0M
ECORelectroCore Inc.$4.84-7.81%$44.7M
HSDTSolana Company Class A Common Stock (DE)$1.64-5.20%$103.1M
FOCLEDAP TMS S.A.$3.17-2.39%$149.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier